Synchron develops endovascular brain-computer interfaces designed to restore functional independence for patients with severe paralysis.
Get unlimited access to analyze competitor ads, save creatives, and discover winning strategies.
See all ads on AdLibrary →Synchron is a medical technology company developing brain-computer interface implants that allow people with paralysis to control digital devices using neural signals, delivered via a minimally invasive endovascular procedure rather than open brain surgery. The company is positioned in the emerging neurotechnology and BCI category, working with research institutions and regulators on clinical trials. It is not a direct-to-consumer retail brand.
